Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Cardiac manifestations of PRKAG2 mutation.

BMC medical genetics - 3 Jan 2018

Banankhah Pooya, Fishbein Gregory A, Dota Anthony, Ardehali Reza

Abstract excerpt

BACKGROUND: The Protein Kinase AMP-Activated Non-Catalytic Subunit Gamma 2 (PRKAG2) cardiac syndrome is characterized by glycogen accumulation in the cardiac tissue. The disease presents clinically with hypertrophic cardiomyopathy (HCM), and it is often associated with conduction abnormalities. CASE PRESENTATION: A 23 year-old female with history of Wolff-Parkinson-White (WPW) and HCM presented for evaluation...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to AMP-Activated Protein Kinases
Share to Angiography
Share to Biopsy

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Cardiomyopathy, Hypertrophic

Share to Chromosomes, Human, Pair 7

Share to Genetic Testing

Share to Myocardium

Source

Open in PubMed Open full text

Identifiers

PMID: 29298659
DOI: 10.1186/s12881-017-0512-6
PMCID: PMC5751825

Genes

PRKAG2

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Cardiac manifestations of PRKAG2 mutation.PMID 29298659Read ↗

PRKAG2 mutation: An easily missed cardiac specific non-lysosomal glycogenosisSemantic proximity Read ↗

High prevalence of arrhythmic and myocardial complications in patients with cardiac glycogenosis due to PRKAG2 mutations.Semantic proximity Read ↗

PRKAG2 cardiac syndrome: familial ventricular preexcitation, conduction system disease, and cardiac hypertrophy.Semantic proximity Read ↗

Clinical Features and Natural History of PRKAG2 Variant Cardiac Glycogenosis.Semantic proximity Read ↗

Genetic testing reveals PRKAG2 syndrome mimicking sarcomeric hypertrophic cardiomyopathy in an adolescent: a case reportSemantic proximity Read ↗

Constitutively active AMP kinase mutations cause glycogen storage disease mimicking hypertrophic cardiomyopathy.Semantic proximity Read ↗

Constitutively active AMP kinase mutations cause glycogen storage disease mimicking hypertrophic cardiomyopathySemantic proximity Read ↗

Glycogen Storage Disease Because of a PRKAG2 Mutation Causing Severe Biventricular Hypertrophy and High-Grade Atrio-Ventricular Block.Semantic proximity Read ↗

Glycogen storage diseases presenting as hypertrophic cardiomyopathy.Semantic proximity Read ↗

Adenosine monophosphate-activated protein kinase disease mimicks hypertrophic cardiomyopathy and Wolff-Parkinson-White syndrome: natural history.Semantic proximity Read ↗

A new mutation in PRKAG2 gene causing hypertrophic cardiomyopathy with conduction system disease and muscular glycogenosis.Semantic proximity Read ↗

Transgenic mice overexpressing mutant PRKAG2 define the cause of Wolff-Parkinson-White syndrome in glycogen storage cardiomyopathy.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.